rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

ORBIMED ADVISORS LLC

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, Andrx Corp /de/; Director and 10% owner, Electra Therapeutics; Director, BlossomHill Therapeutics; Director and 10% owner, Braveheart Bio; Director, Scribe Therapeutics; Director, Sionna Therapeutics; 10% owner, Enliven Therapeutics; Director, Shattuck Labs.

Every Form 4 they filed

In numbers

Trades disclosed
780
Buys
94
Sells
164
Bought
$580.4M
Sold
$754.9M
Companies
77
Companies where not an officer
77
First trade
13 Feb 2006
Last trade
28 Sep 2026
Last filed
30 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Andrx Corp /de/Director, 10% owner · last 28 Sep 20261 buy · 0 sells
ETRA Electra TherapeuticsDirector, 10% owner · Biotechnology · last 21 Sep 20261 buy · 0 sells
BLSM BlossomHill TherapeuticsDirector · Biotechnology · last 10 Aug 20261 buy · 0 sells
BRVE Braveheart BioDirector, 10% owner · Biotechnology · last 7 Aug 20261 buy · 0 sells
SCTX Scribe TherapeuticsDirector · Biotechnology · last 27 Jul 20261 buy · 0 sells
SION Sionna TherapeuticsDirector · Biotechnology · last 7 Jul 20260 buys · 16 sells
ELVN Enliven Therapeutics10% owner · Biotechnology · last 22 Jun 20260 buys · 2 sells
STTK Shattuck LabsDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells
QTTB Q32 BioDirector, 10% owner · Biotechnology · last 28 May 20261 buy · 0 sells
PRLD Prelude TherapeuticsDirector, 10% owner · Biotechnology · last 21 Apr 20262 buys · 0 sells
TRAW Traws Pharma10% owner · Biotechnology · last 16 Apr 20261 buy · 0 sells
IMA ImageneBioDirector · Biotechnology · last 14 Apr 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
702Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—10,690,530filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$1.0M61,516 at $17.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$10.0M588,235 at $17.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—10,690,530 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—2,000,962 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—769,601 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—564,187 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—7,127,019 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—1,333,975 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—513,067 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/option or derivativeSEC FORM 4 Code C—256,448 at $0.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—2,000,962filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—769,601filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—564,187filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Bought$5.1M300,249 at $17.00filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—7,127,019filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—1,333,975filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—513,067filing
28 Sep 2026filed 30 Sep 2026Andrx Corp /de/SEC FORM 4 Code C—256,448filing
21 Sep 2026filed 23 Sep 2026ETRA Electra TherapeuticsBiotechnologySEC FORM 4 Code C—2,002,310filing

The newest 500 lines are listed; the numbers count every line.

Sectors

Health Care156
Not placed102

Buys in green, sells in red, by the company’s sector.

Related people

Carl L. GordonDirector and 10% owner · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Erez ChimovitsDirector · Director at ADARx Pharmaceuticals, filing Form 4 there in the last year
Simeon GeorgeDirector · Director and 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
SR ONE CAPITAL MANAGEMENT, LLC10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
LAV Biosciences Fund V, L.P.10% owner · 10% owner at ADARx Pharmaceuticals, filing Form 4 there in the last year
Benjamin HohlChief Financial Officer · Also traded ELVN in the last 90 days
Helen Louise CollinsChief Medical Officer · Also traded ELVN in the last 90 days
Jodie Pope MorrisonCEO · Also traded QTTB in the last 90 days